← Open Payments lookup

MARK BAPTISTE: Open Payments

NPI 1396271938 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$802 in 47 payments from 8 companies in 2025. Trend: 2023 $99 · 2024 $410 · 2025 $802

Food & beverage: $802
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.13$212
ABBVIE INC.9$141
Neurocrine BioSciences, Inc.6$124
Otsuka America Pharmaceutical, Inc.5$83
Vanda Pharmaceuticals Inc.4$73
E.R. Squibb & Sons, L.L.C.4$65
Janssen Pharmaceuticals, Inc3$54
Lundbeck LLC3$51

Products named: AUSTEDO XR, VRAYLAR, INGREZZA, REXULTI, FANAPT, COBENFY, INVEGA SUSTENNA, UZEDY.

Industry payments across NJ — which companies pay providers there.